
ESTA Stock Forecast & Price Target
ESTA Analyst Ratings
Bulls say
Establishment Labs Holdings Inc is poised for positive growth, driven by anticipated stronger-than-expected sales of its Motiva implants in the U.S. market, coupled with international expansion. The company's management projects an annual revenue growth of over 20% from 2026 to 2028, alongside a transition to cash flow positivity in 2026, primarily fueled by market growth and the success of new products such as Mia and Preservé. The overall outlook suggests that robust revenue growth will enhance margins and cash flow in the forthcoming years.
Bears say
Establishment Labs Holdings Inc is facing a potential decline in revenue growth, with projections falling below 20% primarily due to disappointing sales of its Motiva implants in the United States. Furthermore, the company is at risk from broader economic factors that may negatively impact international sales, as well as concerns about unforeseen complications associated with its products. Additionally, the prospect of a dilutive equity offering further exacerbates the negative outlook, potentially undermining investor confidence and financial stability.
This aggregate rating is based on analysts' research of Establishment Labs Holdings Inc and is not a guaranteed prediction by Public.com or investment advice.
ESTA Analyst Forecast & Price Prediction
Start investing in ESTA
Order type
Buy in
Order amount
Est. shares
0 shares